What’s a corneal epithelial defect?

The cornea is the outermost layer of the human eye, serving both as a protective covering and allowing light into the retina. To perform this function, the cornea is made up of several layers, the outermost of which is known as the epithelium.

Continue reading

RTSM: Finding the right randomization & trial supply management system

One of the most crucial parts of running a clinical trial is managing randomization and drug supply levels. Ensuring that the right participants receive the right dosages of the right medication is essential to gathering accurate study results.

Continue reading

What motivates patients to participate in clinical trials? [Antidote 2023 survey data]

In both 2018 and 2023, Antidote partnered with SCORR marketing to conduct surveys intended to increase the understanding of patients’ perceptions of clinical trials. Our 2018 survey collected data from nearly 4,000 individuals to gain insight into what matters most when considering a clinical trial. Though smaller in scope, the 2023 survey had a similar goal of connecting with patients through ...

Continue reading

What is achondroplasia?

Achondroplasia, also known as achondroplastic dwarfism or ACH, is a rare disorder characterized by short stature, a large head, and short arms and legs. It is the most common type of skeletal dysplasia, the umbrella term that identifies hundreds of conditions, and occurs in about one in 15,000 to 35,000 births.

Continue reading

The evolution of clinical trial recruitment

As the medical research industry is ever-changing, so too is the continuous evolution of effective patient recruitment strategies. To gain more perspective on what these changes have looked like through the years, we chatted with Tom Ruane, the Global Head of Patient Recruitment at Parexel.

Continue reading

Presbyopia: Insights from the Antidote database [infographic]

Presbyopia, the clinical term for age-related farsightedness, is a condition that most people develop as they age. It’s estimated that the prevalence of presbyopia is nearly 80% for individuals between the ages of 45 and 55.

Continue reading

A researcher's perspective: Linking scientific discovery to clinical medicine

For Carla Greenbaum, M.D., growing up in the era of space travel and the moon landing kindled a lifelong interest in science. That interest influenced her career trajectory, and she’s now a leading investigator at Benaroya Research Institute where she has studied the natural history of type 1 diabetes (T1D) since 2000. Her work focuses on finding the cause of autoimmunity and developing targets ...

Continue reading

Patient perspectives: Clinical trials and Diabetes Awareness Month

Each November is designated as Diabetes Awareness Month, an event that highlights the importance of spreading awareness about diabetes and the health issues it can cause.

Continue reading

Creating patient-centric outreach materials for clinical trial patient recruitment [Antidote 2023 survey data]

In 2018, we partnered with SCORR Marketing to conduct a survey aimed at gaining knowledge about the patient perception of clinical trial participation. We collected nearly 4,000 responses from individuals regarding what matters most to when considering a clinical trial.

Continue reading

A guide to clinical trial phases [infographic]

Before any new treatment or therapy is able to be used by the patient population, it must go through the process of a clinical trial — this is the case for any new prescription drug, but also true for over-the-counter medications, medical devices, and more.

Continue reading

Get our latest posts in your inbox